New COVID booster vaccine tested for safety and immune response
NCT ID NCT05542862
Summary
This study tested the SpikoGen vaccine as a booster shot for adults who had already completed their initial COVID-19 vaccinations. Researchers wanted to see how well it worked and how safe it was when given as a third or fourth dose, regardless of which brand of vaccine people got first. They measured the body's immune response and tracked any side effects or new COVID infections.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
ARASMI
Adelaide, South Australia, 5042, Australia
Conditions
Explore the condition pages connected to this study.